Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Etoposide and Capecitabine in Pre-treated Metastatic Breast Cancer
NCT01589159Phase 2Completed
- Start
- Jan 2013
- Primary completion
- Jul 2016
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of capecitabine, etoposide in breast cancer. Started Jan 2013; status: completed.
02
Drugs
capecitabineetoposide
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01589159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01589159.